Incisive Technologies
Natalie Vinh is a seasoned professional in the field of medicinal chemistry and quality assurance, currently serving as a Quality Assurance Manager at Incisive Technologies since October 2024. Previously, Natalie worked as a Senior Scientist at PharmSky Research from May 2022 to October 2024, and at Pfizer from November 2016 to November 2021, where responsibilities included leading the Melbourne extractables and leachables team and collaborating with cross-functional teams on various drug product assessments. Natalie's career began at Monash University, where as a Research Fellow, significant contributions were made in synthesizing aminopeptidase inhibitors for malaria treatment, alongside mentoring honours and PhD candidates. Natalie's educational background includes a Ph.D. in Medicinal Chemistry and an Honours Bachelor's Degree in the same field, both from Monash University.
This person is not in any teams
Incisive Technologies
Incisive Technologies, based in Melbourne Australia, is developing a novel diagnostic for the oral health sector, which is highly sensitive in detecting early-stage tooth decay. The product is a dental paint applied to the teeth by an oral health professional (dentist, orthodontist, hygienist) during regular check-ups to detect problems early so that preventive measures can be used, including remineralisation and better patient education. This approach to oral health helps patients avoid painful and costly restoration due to cavities and assists dentists to implement best-practice preventive care.